M6620 (VX-970) in Selected Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to EMD Serono
Related studies linked through entity extraction aliases.
A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Avelumab With Valproic Acid in Virus-associated Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Exercise and Learning and Memory in Multiple Sclerosis
- Status
- TERMINATED
- Phase
- NA
Adjuvant Avelumab in Merkel Cell Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)
- Status
- COMPLETED
- Phase
- PHASE1
UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Impact of Recombinant Human Growth Hormone on HIV Persistence
- Status
- COMPLETED
- Phase
- PHASE2
Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)
- Status
- TERMINATED
- Phase
- PHASE3
Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
- Status
- COMPLETED
- Phase
- N/A
Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting MS
- Status
- WITHDRAWN
- Phase
- N/A
RESOunD: REbif Satisfaction On Discontinuing Oral Dimethyl Fumarate
- Status
- TERMINATED
- Phase
- PHASE4
Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)
- Status
- TERMINATED
- Phase
- PHASE2
Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3